ADRIANA HUNG

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Comparative effectiveness of incident oral antidiabetic drugs on kidney function
    Adriana M Hung
    VA Tennessee Valley, Clinical Science Research and Development, Geriatric Research Education Clinical Center GRECC, Department of Medicine, Nashville, TN, USA
    Kidney Int 81:698-706. 2012
  2. ncbi CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
  3. ncbi CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System Nashville, TN, USA
    BMC Med Genet 12:65. 2011
  4. ncbi Novel dialysis modalities: do we need new metrics to optimize treatment?
    Rachel Fissell
    Glickman Urological Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Clin Pharmacol 52:72S-8S. 2012
  5. ncbi Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization
    ADRIANA HUNG
    Veterans Administration Tennessee Valley Healthcare System, Clinical Research Center of Excellence and Geriatric Research Education Clinical Center, Nashville, Tennessee, USA
    Hemodial Int 12:236-43. 2008

Research Grants

  1. Inflammation, proteolysis and IL-1beta receptor inhibition in CHD patients
    ADRIANA HUNG; Fiscal Year: 2007

Detail Information

Publications5

  1. ncbi Comparative effectiveness of incident oral antidiabetic drugs on kidney function
    Adriana M Hung
    VA Tennessee Valley, Clinical Science Research and Development, Geriatric Research Education Clinical Center GRECC, Department of Medicine, Nashville, TN, USA
    Kidney Int 81:698-706. 2012
    ..The risk associated with rosiglitazone was similar to metformin for both outcomes. Thus, compared to metformin, oral antidiabetic drug treatment with sulfonylureas increased the risk of a decline in eGFR, ESRD, or death...
  2. ncbi CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
    ..It is unknown if CRP polymorphisms are associated with CKD progression or modify the effectiveness of anti-hypertensive therapy in delaying CKD progression...
  3. ncbi CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System Nashville, TN, USA
    BMC Med Genet 12:65. 2011
    ..We recently reported an association between the gene variant rs2808630 and CKD progression in African Americans with hypertensive kidney disease. This association has not been studied in other ethnic groups...
  4. ncbi Novel dialysis modalities: do we need new metrics to optimize treatment?
    Rachel Fissell
    Glickman Urological Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Clin Pharmacol 52:72S-8S. 2012
    ....
  5. ncbi Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization
    ADRIANA HUNG
    Veterans Administration Tennessee Valley Healthcare System, Clinical Research Center of Excellence and Geriatric Research Education Clinical Center, Nashville, Tennessee, USA
    Hemodial Int 12:236-43. 2008
    ..009). Our results indicate that the presence of a hemodialysis catheter is an independent determinant of an exaggerated inflammatory response in CHD patients representing a potentially modifiable risk factor...

Research Grants2

  1. Inflammation, proteolysis and IL-1beta receptor inhibition in CHD patients
    ADRIANA HUNG; Fiscal Year: 2007
    ..Chronic inflammation is commonly seen in dialysis patients and has been linked to uremic wasting. We want to test if reducing inflammation with an anti-inflammatory treatment will reduce muscle loss in dialysis patients. ..